ISRG reports $2.77B revenue and $2.50 EPS, beating forecasts as da Vinci procedures rise 16% year-over-year. Intuitive Surgical (NASDAQ:ISRG) posted first-quarter revenue of $2.77 billion, surpassing the $2.62 billion estimate, driven by 16% year-over-year growth in da Vin
With an upside potential of 27.1%, Oracle Corporation (NYSE:ORCL) earns its place on our list of the best agentic AI stocks to buy right now. Oracle Corporation (NYSE:ORCL) is solidifying its position as a major enabler of agentic AI in national security, with momentum gro
NVIDIA (NVDA) And SAP Expand Collaboration To Bring Enterprise-Grade Trust And Governance To Specialized AI Agents With an upside potential of 19.0%, NVIDIA Corporation (NASDAQ:NVDA) remains a bullish pick among analysts. The stock, therefore, earns its place on our list o
Alphabet (GOOGL)’s AI Cloud Surge Accelerates As Anthropic Commits $200 Billion To Google Infrastructure With an upside potential of 7.8%, Alphabet Inc. (NASDAQ:GOOGL) earns its place on our list of the best agentic AI stocks to buy right now. Photo by Kai Wenzel on Unspla
With an upside potential of 37.3%, Microsoft Corporation (NASDAQ:MSFT) remains a bullish pick among analysts. The stock, therefore, earns its place on our list of the best agentic AI stocks to buy right now Ken Wolter / Microsoft Corporation (NASDAQ:MSFT) is acceler
SharkNinja will join the S&P MidCap 400 index before trading on May 18, expanding its institutional and passive investor base. SharkNinja (SN) will be added to the S&P MidCap 400 index effective May 18, ahead of the market open. The inclusion is expected to attract more in
Astrana Health reported 56% revenue growth and 82% adjusted EBITDA increase in Q1 2026, prompting multiple price target hikes. Baird increased its price target on Astrana Health (NASDAQ:ASTH) to $45 from $40, citing strengthening fundamentals and margin upside following Q1
Barclays cites a multi-year upstream spending cycle and higher oil prices as drivers for energy services stocks. Barclays increased its price target for Innovex International (INVX) to $26 from $24 while maintaining an Equal Weight rating. The firm highlighted the energy s
Craig-Hallum and KeyBanc lift OMCL price targets to $55 and $70 respectively following strong fiscal Q1 2026 results. Omnicell (NASDAQ:OMCL) saw its price targets raised by two firms after reporting fiscal Q1 2026 earnings. Craig-Hallum increased its target to $55 from $53
Pediatrix Medical Group reported Q1 2026 earnings of $0.36 per share and revenue growth driven by same-unit performance and acquisitions. Mizuho increased its price target for Pediatrix Medical Group (MD) to $24 from $21 after the company released Q1 2026 results. Earnings